Bendamustine and Rituximab As Salvage Therapy In Patients With Chronic Lymphoproliferative Disorders
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This retrospective study collects and evaluates the clinical experience reached in Italy on
the use of bendamustine alone or combined with rituximab as treatment of patients with
relapsed or refractory chronic lymphoproliferative disorders.